Bottom Line
This field currently leans value-positive.
The current preview range spans from $285,604 to $1,193,965. That spread is the core Degreeli point: field choice matters, but so does where and how you pursue it.
High upside
Program Category
Biology/Biotechnology Technologies/Technicians
Degreeli uses field pages to show whether value is consistent or whether the same major swings dramatically depending on the school, price point, and completion environment.
Offerings In Preview Catalog
3
Positive ROI Routes
3/3
Best Current ROI
$1,193,965
Fastest Payback
6.3 years
What To Compare
Stack payback speed against downside, not just upside.
Families should read this category through three questions: which school delivers the best risk-adjusted upside, how fast the cost gets recouped, and how much value evaporates once completion risk enters the picture.
School-Level Routes
Where Biology/Biotechnology Technologies/Technicians currently looks strongest
BACHELORS
The Pennsylvania State University--University Park
Degreeli Score
49/100
High Risk
Data Confidence
Medium
Completion-Adjusted ROI
$1,193,965
Years To Recoup
11.5 years
On-Time ROI
$1,386,880
10-Year Earnings
$75,919
Why it scores this way
Strength: Completion/outcome signal supports the value case.
Risk: Debt risk rises quickly if borrowing approaches the modeled estimate.
BACHELORS
Pennsylvania State University--Berks
Degreeli Score
51/100
High Risk
Data Confidence
Medium
Completion-Adjusted ROI
$447,885
Years To Recoup
8.6 years
On-Time ROI
$1,420,956
10-Year Earnings
$75,919
Why it scores this way
Strength: Cost looks efficient relative to expected early-career pay.
Risk: Payback could take longer than many families expect.
BACHELORS
Pennsylvania State University--Abington
Degreeli Score
60/100
Caution Zone
Data Confidence
Medium
Completion-Adjusted ROI
$285,604
Years To Recoup
6.3 years
On-Time ROI
$1,446,096
10-Year Earnings
$75,919
Why it scores this way
Strength: Cost looks efficient relative to expected early-career pay.
Risk: Completion or outcome confidence needs more scrutiny.